Event Reminder! Sarepta Therapeutics, developer of the experimental Duchenne muscular dystrophy drug eteplirsen, will host a webcast and conference call for the Duchenne muscular dystrophy (DMD) community tomorrow, May 13, beginning at 11 a.m. EDT (8 a.m. PDT / 5 p.m. CEST). For more information on how to join the webcast, visit ow.ly/wggpG. For background information, see MDA Thrilled FDA Will Consider Accelerated Approval for New Muscle Disease Drug Aimed at DMD at mda.org/media/press-releases/mda-thrilled-fda-will-consider-accelerated-approval-new-muscle-disease-drug and A Landmark Development for the Duchenne MD Community at mda.org/page/landmark-development-duchenne-md-community.
Posted on: Mon, 12 May 2014 23:25:00 +0000
Trending Topics
Recently Viewed Topics
© 2015